TRANSCODE THERAPEUTICS INC
Q3 2026 13F Holders
Symbol
RNAZ
CUSIP
89357L501
Type
Equity
Class
COM NEW 2025
Num filings
2
Total reported value, excl. options
$33.00
Compare 2026 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
Manager
Report Date
Value ($000)
Shares
Option Type